3H PHARMACIES LTDActive

Company number 07265181Private limited companyIncorporated 2010

Key figures

£179,591+361.2%
Net assets 2024/25
+9.6%
Average annual growth 2019/20–2024/25
050 k100 k150 k200 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, 3H PHARMACIES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand197,858280,78392,86354,75690,183
Total assets730,391700,443597,290592,402782,064
Total liabilities558,063529,994535,129553,461602,473
Net assets / total equity172,328170,44962,16138,941179,591
Average number of employees9981011

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: 3H PHARMACIES LTD

Company

3H PHARMACIES LTD is a private limited company registered with Companies House under company number 07265181. It was incorporated on 26 May 2010. Its status is active. The registered office is in Burton-on-trent (DE14). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £179,591, up 361.2% on the previous year. Cash at bank and in hand was £90,183. Total assets were £782,064 and total liabilities £602,473. The company had an average of 11 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 1 of 6 registered charges are outstanding.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 31 Jul 2027.